Brady Davis Joins Contextual Genomics’ Executive Team
VANCOUVER, British Columbia–(BUSINESS WIRE)–#cancergenomics–Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive…
Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia–(BUSINESS WIRE)–#cancergenomics–Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive…
MILAN & MORRISTOWN, N.J.–(BUSINESS WIRE)–$NWRN—Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of…
MILAN & MORRISTOWN, N.J.–(BUSINESS WIRE)–$NWRN—Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of…
CAMBRIDGE, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–F-star Therapeutics (“F-star”), a clinical-stage biopharmaceutical company focused on transforming the lives of patients with…
CAMBRIDGE, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–F-star Therapeutics (“F-star”), a clinical-stage biopharmaceutical company focused on transforming the lives of patients with…
SALT LAKE CITY–(BUSINESS WIRE)–#AlucentBiomedical—Alucent Biomedical Inc. has received U.S. Food and Drug Administration approval to proceed with a Phase 1…
SALT LAKE CITY–(BUSINESS WIRE)–#AlucentBiomedical—Alucent Biomedical Inc. has received U.S. Food and Drug Administration approval to proceed with a Phase 1…
Ionis to leverage Aro’s CENTYRIN technology to develop a new class of innovative medicines designed to selectively target antisense oligonucleotides…
Data from MEDALIST showed significant clinical benefit of Reblozyl in treating anemia in adults with myelodysplastic syndromes PRINCETON, N.J. &…
Data from MEDALIST showed significant clinical benefit of Reblozyl in treating anemia in adults with myelodysplastic syndromes PRINCETON, N.J. &…